ProfileGDS5678 / 1417339_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 98% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 111.519399
GSM967853U87-EV human glioblastoma xenograft - Control 211.424599
GSM967854U87-EV human glioblastoma xenograft - Control 311.558499
GSM967855U87-EV human glioblastoma xenograft - Control 411.39999
GSM967856U87-EV human glioblastoma xenograft - Control 511.415299
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 110.776999
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 210.406598
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 310.935299
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.79699
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 111.279199
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 211.329799
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 311.376899
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 411.468899
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 511.550899